期刊文献+

冠心病患者血浆sOX40L与MMP-9检测的临床意义 被引量:2

Significance of determination of sOX40L and matrix metalloproteinases-9 in patients with coronary artery disease
下载PDF
导出
摘要 目的探讨冠心病患者血浆sOX40L和血清基质金属蛋白酶-9(MMP-9)变化水平及其与动脉粥样硬化易损斑块的关系。方法采用酶联免疫吸附法检测sOX40L、MMP-9。所有患者均行冠状动脉造影,计算冠状动脉病变形态积分并与sOX40L,MMP-9水平进行相关分析。结果急性冠状动脉综合征(ACS)组sOX40L及MMP-9水平显著高于稳定型心绞痛(SAP)组和正常组(P<0.05),而后两组间差异无统计学意义(P>0.05);ACS组冠状动脉狭窄病变形态积分明显高于SAP组和正常组(P<0.05),后两组间病变积分差异无统计学意义(P>0.05);ACS组sOX40L及MMP-9水平均与冠状动脉造影狭窄病变形态积分有明显相关性(P<0.05)。结论冠心病患者sOX40L及MMP-9水平升高可能提示斑块不稳定,可有效判断冠状动脉病变程度预测急性冠状动脉事件的发生。 Objective To explore the relationship between sOX40L, MMP-9 and stability of coronary atheresclerotic plaque in patients with coronary heart disease (CHD). Methods The morphology of plasma sOX40L and MMP-9 were determined with ELISA.. All patients were identified with coronary angiography (CAG) . All coronary stenoses with ≥ 50% diameter reduction were assessed by angiographic coronary stenosis morphology. Results (1) the level of serum sOX40L and MMP-9 in ACS group were significantly higher than SA and control groups ( P 〈 0.05) . But there was no significant difference between SA group and control group (P〉0.05) ;(2) the score of angiography morphology of coronary lesions in ACS group was significantly higher than that of SA and control groups ( P 〈 0.05). But there were no significant difference between SAP group and control group ( P 〉0.05);(3) the levels of sOX40L and MMP-9 were correlated with the coronary severity scores (r1 =0.52 p〈0.05, r2 =0.41 p〈0.05).(4) Correlation analysis suggested the levels of sOX40L were positively correlated with MMP-9 (p〈0.05). Conclusion The elevated levels of serum sOX40L, MMP-9 in ACS suggested that they may enhance the inflammation, aggravate the development of atherosclerosis and mediate the plaque destabilization . They can be served as a valuable marker for evaluating the degree of coronary artery pathology and forecasting clinical risk in ACS.
出处 《中国热带医学》 CAS 2008年第12期2119-2121,共3页 China Tropical Medicine
关键词 急性冠脉综合征 SOX40L 基质金属蛋白酶-9 Acute coronary syndrome sOX40L Matrix metalloproteinases-9
  • 相关文献

参考文献11

  • 1Chyu KY,Shah PK.The role of inflammation in plaquedisruption and thrombosis [J].RevCardiovasc Med,2001,2(2):82-91.
  • 2Wang X,Ria M,Kelmenson PM,et al.Positional identification of TNFSF4, encoding OX40 ligan d,as a gene that influences atherosclerosis susceptibility [ J ].Nat Genet, 2005,4(37) : 365-372.
  • 3Ria M ,Eriksson P ,Boquist S,et al .Human genetic evidence that OX40 is implicated in myocardial infarction .Biochem Biophys ResCommun,2006,339:1001 - 1006.
  • 4Kaski JC,Chester MR,Chen 1, Katritsis D.Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology.Circulation 1995;92:2058-65.
  • 5张涛,李自成,巫少荣.基质金属蛋白酶-9和C反应蛋白与冠心病的相关性研究[J].临床心血管病杂志,2008,24(2):88-90. 被引量:22
  • 6Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome[J].Am Heart J 2001;141:211- 217.
  • 7Croft M. Co-stimulatory members of the TNFR family:keys to effective T-cell immunity[J]. Nat Rev Immunol,2003,3:609-620.
  • 8Sugamura k.Ishii N,Weinberg AD. Therapeutic targeting if the effector T-cell co-stimulatory molecule OX40 [J]. Nat Rev Immunol,2004,4: 420-431.
  • 9Van Wanrooij EJ,Van Puijvelde GH,De Vos P,et al.Interruption of the Tnfrsf4/rnfsf4 (OX40OX40L)pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice [J].Arterioscler Throm Vase Biol, 2007,27(1) : 204-210
  • 10刘红莉,柳茵,刘维军,李琳.急性冠脉综合征患者血浆sOX40L、sP选择素的变化水平及与冠脉病变的相关性研究[J].青海医学院学报,2007,28(2):78-82. 被引量:4

二级参考文献21

  • 1张涛,李自成.冠心病易损斑块的研究进展[J].临床心血管病杂志,2004,20(8):509-512. 被引量:18
  • 2程翔,廖玉华.炎症与动脉粥样硬化[J].中华心血管病杂志,2004,32(5):475-477. 被引量:86
  • 3刘海波,高润霖,陈在嘉,姚康宝,陈纪林,杨跃进,乔树宾,徐义枢.不稳定性心绞痛患者冠状动脉造影形态学特点及其意义[J].中国循环杂志,1996,11(1):3-5. 被引量:32
  • 4王燃燃,彭道泉,赵水平.冠心病相关的炎症新指标OX40L[J].中华心血管病杂志,2006,34(12):1110-1112. 被引量:25
  • 5Chyu KY,Shah PK.The role of inflammation in plaque disruption and thrombosis[J].RevCardiovasc Med,2001,2(2):82-91
  • 6Wang X,Ria M,Kelmenson PM,et al.Positional identification of TNFSF4,encoding OX40 ligand,as a gene that influences atherosclerosis susceptibility[J].Nat Genet,2005,4(37):365-372
  • 7Van Wanrooij EJ,Van Puijvelde GH,De Vos P,et al.Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.Arterioscler Throm Vasc Biol,2007,27 (1):204-210
  • 8Nohara C,Akiba H,Nakajima A,et a1.Amelioration of experimental autoimmune encephalomyolitis with anti-OX40 ligand monoclonal antibody:a critical role for OX40 ligand in migration,but not development,of pathogenic T cells.J Immunol,2001,166:2108-2l15
  • 9Yan JC,Zhu J,Gao L,et al.The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes[J].Clin Chim Acta,2004,343(1-2):155-159
  • 10Ridker PM,Hennekens CH,Buring JE,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].N Engl J Med,2000,342(12):836-843

共引文献23

同被引文献30

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部